Robert Bertoldi

The American Institute of Certified Public Accountants provides vocational education in accounting. The company provides services to the accounting community, regulatory bodies, and other organizations. It also operates in Jersey City, Washington, and Lewisville. It was founded in 1887 and is headquartered in New York City, NY.

Amphion Capital Partners LLC used to create, develop and operate healthcare and technology companies in partnership with corporations, universities and others seeking to profitably commercialize intellectual property. Focusing on long-term growth and profitability, the company's management team had collectively created and developed more than 50 technology-driven companies in the information technology, physical and life sciences industries. In the physical and life sciences industries, these companies include Celgene, Medisense, Quidel, and SEQUUS. The company was headquartered in New York, NY.

m2m Imaging Corp. develops and manufactures preclinical and clinical imaging system accessories. It offers preclinical MR coils, such as integrated coil systems, surface coils, volume coils, arrays, Hi B1 field uniformity BioSAW coils, multi nuclei coils, coils for horizontal and vertical bore systems, and Bruker and Agilent platforms. The company was founded by Jon T. Devries and Erzhen Gao in 1999 and is headquartered in Cleveland, OH.

New York State Society of Certified Public Accountants is a non-profit organization. It provides a membership program for certified public accountants that offers in-person and online networking opportunities, Continuing Professional Education courses and conferences, the CPA Journal, and other publications. The company was foudned in 1897 and is headquartered in New York, NY.

DataTern, Inc. commercializes selected intellectual property technology opportunities which originate from Amphion’s Partner Companies. Its two patents (the ‘502 and ‘402 patents) are directed to how object-oriented software applications access data stored in relational databases. The company is headquartered in New York, NY.

Motif Bio Plc is a clinical stage biopharmaceutical company, which engages in the development and commercialization of pharmaceutical formulations. The company focuses on developing novel antibiotics designed to be effective against serious and life-threatening infections caused by multi-drug resistant bacteria. It offers Iclaprim, a novel diaminopyrimidine antibiotic that inhibits an essential bacterial enzyme called dihydrofolate reductase. The company was founded by Jonathan E. Gold on November 20, 2014 and is headquartered in Princeton, NJ.